Prevalence and Treatment of Pain in EDs in the United States, 2000 to 2010
Overview
Affiliations
Objectives: To describe changes in the prevalence and severity of pain and prescribing of non-opioid analgesics in US emergency departments (EDs) from 2000 to 2010.
Methods: Analysis of serial cross-sectional data regarding ED visits from the National Hospital Ambulatory Medical Care Survey. Visits were limited to patients ≥18 years old without malignancy. Outcome measures included annual volume of visits among adults with a primary symptom or diagnosis of pain, annual rates of patient-reported pain severity, and predictors of non-opioid receipt for non-malignant pain.
Results: Rates of pain remained stable, representing approximately 45% of visits from 2000 through 2010. Patients reported pain as their primary symptom twice as often as providers reported a primary pain diagnosis (40% vs 20%). The percentage of patients reporting severe pain increased from 25% (95% confidence intervals [CI] 22%-27%) in 2003 to 40% (CI 37%-42%) in 2008. From 2000 to 2010, the proportion of pain visits treated with pharmacotherapies increased from 56% (CI 53%-58%) to 71% (CI 69%-72%), although visits treated exclusively with non-opioids decreased 21% from 28% (CI 27%-30%) to 22% (CI 20%-23%). The adjusted odds of non-opioid rather than opioid receipt were greater among visits for patients 18 to 24 years old (odds ratio [OR] 1.35, CI 1.24-1.46), receiving fewer medicines (OR 2.91, CI 2.70-3.15) and those with a diagnosis of mental illness (OR 2.24, CI 1.99-2.52).
Conclusions: Large increases in opioid utilization in EDs have coincided with reductions in the use of non-opioid analgesics and an unchanging prevalence of pain among patients.
Sommers S, Tolle H, Trinkley K, Johnston C, Dietsche C, Eldred S JMIR Med Inform. 2024; 12:e58276.
PMID: 39504560 PMC: 11560079. DOI: 10.2196/58276.
Naser A, Alshehri H BMJ Open. 2023; 13(11):e080503.
PMID: 38000821 PMC: 10680006. DOI: 10.1136/bmjopen-2023-080503.
Horn M, Simon C, Lee H, Eucker S Mayo Clin Proc Innov Qual Outcomes. 2023; 7(5):490-498.
PMID: 37842687 PMC: 10568062. DOI: 10.1016/j.mayocpiqo.2023.08.001.
Engel-Rebitzer E, Dolan A, Shofer F, Schapira M, Hess E, Rhodes K Am J Emerg Med. 2023; 74:84-89.
PMID: 37797399 PMC: 10924766. DOI: 10.1016/j.ajem.2023.09.016.
Cattin G, Jenvrin J, Hardouin J, Longo C, Montassier E Trials. 2022; 23(1):1016.
PMID: 36522767 PMC: 9756523. DOI: 10.1186/s13063-022-06943-0.